Cardiovascular diseases (CVD) are the leading cause of death and disability in the world, with a major impact on longevity and healthcare costs in the U.S. Dr. Smoum-Jaouni examines the endocannabinoid system, CB 1 and CB 2 expression in the CV system, and the impact of cannabis on the regulation of vessel contractility. Specific diseases will be discussed including diabetes, atherosclerosis and restenosis, and ischemia/reperfusion injury.
Purchase of this medical cannabis education course grants one learner one year’s access to lessons and quizzes (access expires 365 days from date of course activation).
Reem Smoum-Jaouni, PhD
Dr. R. Smoum-Jaouni was born in Jerusalem. She received her Masters Degree in Biophysical Chemistry from the University of Bergen in Norway and her Ph.D. in Medicinal Chemistry from the Hebrew University in Jerusalem. She completed her postdoctoral research in cannabinoid research at the Hebrew University. She is currently with the Institute for Drug Research and the Institute of Dental Sciences at the Faculty of Medicine at the Hebrew University. She is a Research Scientist at the labs of Prof. Raphael Mechoulam and Prof. Itai Bab. Her research interests are in the field of the chemistry and biological activity of cannabinoids and related novel drugs. These compounds are tested against osteoporosis, pain, inflammation, high blood pressure, trauma and cardiovascular diseases. She has been working in the cannabinoid research field for 8 years.